EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 33 / Numéro 1 (Janvier 2017) Med Sci (Paris), 33 1 (2017) 32-38 Références
Accès gratuit
Numéro
Med Sci (Paris)
Volume 33, Numéro 1, Janvier 2017
Matériaux pour la médecine de demain
Page(s) 32 - 38
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20173301006
Publié en ligne 25 janvier 2017
  1. Préparations parentérales-Implants. Pharmacopée Européenne 8.4, 2014 : 5013–5015. [Google Scholar]
  2. Hornez JC, Chai F, Monchau F, et al. Biological and physico-chemical assessment of hydroxyapatite (HA) with different porosity. Biomol Eng 2007 ; 24 : 505–509. [CrossRef] [PubMed] [Google Scholar]
  3. Touzet S, Ferri J, Wojcik T, Raoul G. Complications of calvarial bone harvesting for maxillofacial reconstructions. J Craniofac Surg 2011 ; 22 : 178–181. [CrossRef] [PubMed] [Google Scholar]
  4. Romanò CL, Romanò D, Logoluso N, Drago L. Bone and joint infections in adults: a comprehensive classification proposal. Eur Orthop Traumatol 2011 ; 1 : 207–217. [CrossRef] [PubMed] [Google Scholar]
  5. Flury BB, Elzi L, Kolbe M, et al. Is switching to an oral antibiotic regimen safe after 2 weeks of intravenous treatment for primary bacterial vertebral osteomyelitis? BMC Infect Dis 2014 ; 14 : 226. [CrossRef] [PubMed] [Google Scholar]
  6. Chai F, Hornez JC, Blanchemain N, et al. Antibacterial activation of hydroxyapatite (HA) with controlled porosity by different antibiotics. Biomol Eng 2007 ; 24 : 510–514. [CrossRef] [PubMed] [Google Scholar]
  7. Leprêtre S, Chai F, Hornez JC, et al. Prolonged local antibiotics delivery from hydroxyapatite functionalized with cyclodextrin polymers. Biomaterials 2009 ; 30 : 6086–6093. [CrossRef] [PubMed] [Google Scholar]
  8. Schuessele A, Mayr H, Tessmar J, Goepferich A. Enhanced bone morphogenetic protein-2 performance on hydroxyapatite ceramic surfaces. J Biomed Mater Res A 2009 ; 90 : 959–971. [CrossRef] [PubMed] [Google Scholar]
  9. Lee WH, Loo CY, Rohanizadeh R. A review of chemical surface modification of bioceramics: effects on protein adsorption and cellular response. Colloids Surf B Biointerfaces 2014 ; 122 : 823–834. [CrossRef] [PubMed] [Google Scholar]
  10. Xu Q, Czernuszka JT. Controlled release of amoxicillin from hydroxyapatite-coated poly(lactic-co-glycoloc acid) microspheres. J Controlled Release 2008 ; 127 : 146–153. [CrossRef] [Google Scholar]
  11. Liu H, Li H, Cheng W, et al. Novel injectable calcium phosphate/chitosan composites for bone substitute materials. Acta Biomater 2006 ; 2 : 557–565. [CrossRef] [PubMed] [Google Scholar]
  12. Berger J, Reist M, Mayer JM, et al. Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur J Pharm Biopharm 2004 ; 57 : 19–34. [CrossRef] [PubMed] [Google Scholar]
  13. Rinaudo M. Chitin and chitosan: properties and applications. Prog Polym Sci 2006 ; 31 : 603–632. [Google Scholar]
  14. Palao-Suaya R, Gómez-Mascaraque LG, Aguilara MR, et al. Self-assembling polymer systems for advanced treatment of cancer and inflammation. Progr Polymer Science 2016 ; 53 : 207–248. [CrossRef] [Google Scholar]
  15. Bhattarai N, Gunn J, Zhang M. Chitosan-based hydrogels for controlled, localized drug delivery. Adv Drug Deliv Rev 2010 ; 62 : 83–99. [Google Scholar]
  16. Muzzarelli RAA. Genipin-crosslinked chitosan hydrogels as biomedical and pharmaceutical aids. Carbohydr Polym 2009 ; 77 : 1–9. [Google Scholar]
  17. Aubert-Viard F, Martin A, Chai F, et al. Chitosan finishing nonwoven textiles loaded with silver and iodide for antibacterial wound dressing applications. Biomed Mater 2015 ; 10 : 015023. [CrossRef] [PubMed] [Google Scholar]
  18. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004 ; 350 : 221–231. [Google Scholar]
  19. Kastrati A, Mehilli J, Pache J, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007 ; 356 : 1030–1039. [Google Scholar]
  20. Finn AV, Kolodgie FD, Harnek J, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 2005 ; 112 : 270–278. [CrossRef] [PubMed] [Google Scholar]
  21. Virmani R, Guagliumi G, Farb A, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 2004 ; 109 : 701–705. [CrossRef] [PubMed] [Google Scholar]
  22. Lee H, Dellatore SM, Miller WM, Messersmith PB. Mussel-inspired surface chemistry for multifunctional coatings. Science 2007 ; 318 : 426–430. [Google Scholar]
  23. Weng Y, Song Q, Zhou Y, et al. Immobilization of selenocystamine on TiO2 surfaces for in situ catalytic generation of nitric oxide and potential application in intravascular stents. Biomaterials 2011 ; 32 : 1253–1263. [CrossRef] [PubMed] [Google Scholar]
  24. Chien CY, Tsai WB. Poly(dopamine)-assisted immobilization of Arg-Gly-Asp peptides, hydroxyapatite, and bone morphogenic protein-2 on titanium to improve the osteogenesis of bone marrow stem cells. ACS Appl Mater Interfaces 2013 ; 5 : 6975–6983. [Google Scholar]
  25. Poh CK, Shi Z, Lim TY, et al. The effect of VEGF functionalization of titanium on endothelial cells in vitro. Biomaterials 2010 ; 31 : 1578–1585. [CrossRef] [PubMed] [Google Scholar]
  26. Sobocinski J, Laure W, Taha M, et al. Mussel inspired coating of a biocompatible cyclodextrin based polymer onto CoCr vascular stents. ACS Appl Mater Interfaces 2014 ; 6 : 3575–3586. [Google Scholar]
  27. Pérez-Anes A, Gargouri M, Laure W, et al. Bioinspired titanium drug eluting platforms based on a Poly-β-cyclodextrin-chitosan layer-by-layer self-assembly targeting infections. ACS Appl Mater Interfaces 2015 ; 7 : 12882–12893. [Google Scholar]
  28. Jaschke B, Michaelis C, Milz S, et al. Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform. Cardiovasc Res 2005 ; 68 : 483–492. [CrossRef] [PubMed] [Google Scholar]
  29. Beckman JA, Creager MA. The nonlipid effects of statins on endothelial function. Trends Cardiovasc Med 2006 ; 16 : 156–162. [CrossRef] [PubMed] [Google Scholar]
  30. Jacobson JR, Barnard JW, Grigoryev DN, et al. Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol 2005 ; 288 : 1026–1032. [Google Scholar]
  31. Juhn S, Rybak L. Labyrinthine barriers and cochlear homeostasis. Acta Otolaryngol 1981 ; 91 : 529–534. [CrossRef] [PubMed] [Google Scholar]
  32. Leary Swan EE, Mescher MJ, Sewell WF, et al. Advanced inner ear drug delivery for auditory applications. Adv Drug Deliv Rev 2008 ; 60 : 1583–1599. [CrossRef] [PubMed] [Google Scholar]
  33. Gehrke M, Sircoglou J, Vincent C, et al. How to adjust dexamethasone mobility in silicone matrices: a quantitative treatment. Eur J Pharm Biopharm 2016 ; 100 : 27–37. [CrossRef] [PubMed] [Google Scholar]
  34. Gehrke M, Sircoglou J, Gnansia D, et al. Ear cubes for local controlled drug delivery to the inner ear. Int J Pharm 2016 ; 509 : 85–94. [CrossRef] [PubMed] [Google Scholar]
  35. El Kechai N, Agnely F, Mamelle E, et al. Recent advances in local drug delivery to the inner ear. Int J Pharm 2015 ; 494 : 83–101. [CrossRef] [PubMed] [Google Scholar]
  36. Krenzlin S, Vincent C, Munzke L, et al. Pedictability of drug release from cochlear implants. J Control Rel 2012 ; 159 : 60–68. [CrossRef] [Google Scholar]
  37. Douchement D, Terranti A, Lamblin J, et al. Dexamethasone eluting electrodes for cochlear implantation: Effect on residual hearing. Cochlear Implants Int 2015 ; 16 : 195–200. [CrossRef] [PubMed] [Google Scholar]
  38. Pascale D, Gordon J, Lamster I, et al. Concentration of doxycycline in human gingival fluid. J Clin Periodontol 1986 ; 13 : 841–844. [CrossRef] [PubMed] [Google Scholar]
  39. Greenstein G, Tonetti M. The role of controlled drug delivery for periodontitis. J Periodontol 2000 ; 71 : 125–140. [Google Scholar]
  40. Schwach-Abdellaoui K, Vivien-Castioni N, Gurny R. Local delivery of antimicrobial agents for the treatment of periodontal diseases. Eur J Pharm Biopharm 2000 ; 50 : 83–99. [CrossRef] [PubMed] [Google Scholar]
  41. Bonito AJ, Lux L, Lohr KN. Impact of local adjuncts to scaling and root planing in periodontal disease therapy: a systematic review. J Periodontol 2005 ; 76 : 1227–1236. [CrossRef] [PubMed] [Google Scholar]
  42. ANSM. Recommandations de bonnes pratiques. Prescription des antibiotiques en pratique bucco-dentaire, juillet 2011 (http://ansm.sante.fr/var/ansm_site/storage/original/application/753c041773b2cebeab1ec25bdba06d33.pdf). [Google Scholar]
  43. Do MP, Neut C, Delcourt E, et al. In situ forming implants for periodontitis treatment with improved adhesive properties. Eur J Pharm Biopharm 2014 ; 88 : 342–350. [CrossRef] [PubMed] [Google Scholar]
  44. Do MP, Neut C, Metz H, et al. Mechanistic analysis of PLGA/HPMC-based in-situ forming implants for periodontitis treatment. Eur J Pharm Biopharm 2015 ; 94 : 273–283. [CrossRef] [PubMed] [Google Scholar]
  45. Do MP, Neut C, Metz H, et al. In-situ forming composite implants for periodontitis treatment: How the formulation determines system performance. Int J Pharm 2015 ; 486 : 38–51. [CrossRef] [PubMed] [Google Scholar]
  46. Jordana F, Le Visage C, Weiss P. Substituts osseux. Med Sci (Paris) 2017 ; 33 : 60–65. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.